We wish we’d written that: STAT staffers share their favorite stories of 2023
It’s time to take stock of the year that was in health and science: the meteoric rise of weight loss drugs, the approval of the first CRISPR-based therapy, the continuing effects of abortion access restrictions after the Dobbs decision, and much more.
Below is our annual list of stories that STAT staffers loved, and wish that they had written. (Also check out the jealousy list from Bloomberg Businessweek, which had the idea first.)
